secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2022-07-05T23:59:59+00:00
Accession:  0001104659-22-077083
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eloxx Pharmaceuticals appoints Lindsay Androski to board; five directors resign, board shrinks from nine to five
--------------------------------------------------------------------------------

- Five directors (Gadi Veinrib, Ran Nussbaum, Zafrira Avnur, Rajesh Parekh, Jasbir Seehra) resign effective July 1, 2022.
- Board size reduced from nine to five directors; Alan Walts and Tomer Kariv appointed as committee chairs.
- Lindsay Androski appointed to fill vacancy, joining Audit and Compensation Committees.
- Androski is President/CEO of Roivant Social Ventures and was part of founding team at Roivant Sciences.
- Company states resignations not due to any disagreement; aims for a 'nimble and focused' board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465922077083/0001104659-22-077083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465922077083/tm2219962d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-077083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer